Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.

Saved in:
Bibliographic Details
Title: Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.
Authors: Arnold SD; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Bakshi N; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Ross D; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Smith C; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Sinha C; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Veludhandi A; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Dutreuil V; Pediatric Biostatistics Core, Department of Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA., Bai S; Pediatric Biostatistics Core, Department of Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA., Meacham LR; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Guilcher G; Alberta Children's Hospital, Calgary, Alberta, Canada., Bhatia M; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, New York, USA., Abraham A; Children's National Hospital, Washington, DC, USA.; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Kasow KA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA., Haight A; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., El Rassi F; Georgia Comprehensive Sickle Cell Center at Grady Health System, Emory University School of Medicine, Atlanta, Georgia, USA., Stenger E; Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Lipscomb J; Emory University Rollins School of Public Health, Atlanta, Georgia, USA., Krishnamurti L; Section of Pediatric Hematology/Oncology/BMT, Yale School of Medicine, New Haven, Connecticut, USA.
Source: American journal of hematology [Am J Hematol] 2024 Oct; Vol. 99 (10), pp. 2037-2040. Date of Electronic Publication: 2024 Aug 06.
Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1096-8652
DOI:10.1002/ajh.27436